Greenhill, L.L., Abikoff, H.B., Arnold, L.E., Cantwell, D.P., Conners, C.K., Elliott, G., Hechtman, L., Hinshaw, S.P. , Hoza, B., Jensen, P.S., Kraemer, H.C., March, J.S., Newcorn, J.H. , Pelham, W.E., Richters, J.E., Schiller, E.P., Severe, J.B., Swanson, J.M. , Vereen, D. , Wells, K.C. (1996). Medication treatment strategies in the MTA: Relevance to clinicians and researchers. Journal of the American Academy of Child & Adolescent Psychiatry, 35 (10), 1304-1313.
2.
Jacobsen, N.S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
3.
Richters, J., Arnold, E. , Jensen, P., Abikoff, H., Conners, K., Greenhill, L., Hechtman, L., Hinshaw, S., Pelham, W., Swanson, J. ( 1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: 1. Background and rationale. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 987-1000.
4.
Spencer, T., Biederman, J. , Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child & Adolescent Psychiatry, 35 (4), 409-432.
5.
Sprafkin, J., Gadow, K. (1996). Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology, 6 (4), 215-228.
6.
Wallace, A., & Kofoed, L. (1994). Statistical analysis of single case studies in the clinical setting: The example of methylphenidate trials in children with attention-deficit hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology, 4 (3), 141-150.
7.
Weisz, J., Donenberg, G. , Weiss, B., Hari, S. (1995). Bridging the gap between laboratory and clinic in child and adolescent study method yields unbiased estimates.
